Primary Palliative Care for Patients With Advanced Hematologic Malignancies
Completed · Not applicable
Conditions studied: Advanced Cancer
In brief
This study seeks to develop and pilot-test an oncology nurse-led care management intervention to meet the primary palliative care needs of patients with advanced hematologic malignancies.
Key facts
- Study ID
- NCT02992171
- Run by
- University of Pittsburgh
- People needed
- 60
- Starts
- 2017-05-02
- Expected to finish
- 2020-03-19
- Last updated by the study team
- 2020-04-24
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- adults (≥ 21 years old)
- Refractory or Recurrent hematologic cancer: lymphoma, leukemia, myeloma, amyloidosis (secondary manifestation myeloma \& AL Amyloidosis), and CML (CML can only be accelerated or blast phase)
- planning to receive ongoing care from a participating oncologist and willing to be seen at least monthly.
You may not qualify if…
- chronic myeloid leukemia (CML) OTHER THAN accelerated or blast phase
- unable to read and respond to questions in English
- lacks decision-making capacity, as determined by the patient's oncologist
- unable to complete baseline interview
- Caregiver
- Inclusion Criteria:
- adults (≥ 21 years old)
- family member or friend of an eligible patient
- Exclusion criteria:
- unable to read and respond to questions in English
- unable to complete the baseline interview (patients will be asked to select as caregiver the person who is most likely to accompany them to visits or help with their care should they need it)
- Eligible clinicians will be oncology nurses and oncologists practicing at participating clinics.
Where it is running
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.